10x Genomics (TXG) Change in Inventory (2018 - 2026)

10x Genomics (TXG) has 9 years of Change in Inventory data on file, last reported at -$2.7 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Inventory rose 66.47% year-over-year to -$2.7 million; the trailing twelve-month figure through Mar 2026 stood at -$22.6 million (down 174.97% YoY), and the FY2025 full-year result was -$28.0 million, down 385.91% from the prior year.
• Change in Inventory climbed to -$2.7 million in Q1 2026, from -$5.6 million in the prior quarter.
• In the past five years, Change in Inventory ranged from a high of $9.9 million in Q1 2024 to a low of -$9.6 million in Q4 2024.
• A 5-year average of -$444529.4 and a median of $449000.0 in 2023 frame the typical range for Change in Inventory.
• Across the five-year window, Change in Inventory tumbled 632.08% in 2023 and surged 2113.14% in 2024, its largest moves.
• Tracing TXG's Change in Inventory over 5 years: stood at $1.4 million in 2022, then plunged by 632.08% to -$7.6 million in 2023, then slipped by 26.33% to -$9.6 million in 2024, then soared by 41.97% to -$5.6 million in 2025, then surged by 51.59% to -$2.7 million in 2026.
• Business Quant data shows TXG's Change in Inventory at -$2.7 million in Q1 2026, -$5.6 million in Q4 2025, and -$7.3 million in Q3 2025.